Imperial College London is a core academic partner of the COG-UK consortium. Imperial is leading the G2P-UK National Virology Consortium which is studying how SARS-CoV-2 mutations affect how transmissible the virus is, the severity of COVID-19 it causes, and the effectiveness of vaccines and treatments.
Contributors:
- Professor Neil Ferguson, Faculty of Medicine, School of Public Health
- Dr Erik Volz, Faculty of Medicine, School of Public Health [ORCID] [Profile] [Researchgate]
- Dr Aileen Rowan, Faculty of Medicine, Department of Immunology and Inflammation [GoogleScholar] [LinkedIN] [Profile] [Researchgate]
- Professor Graham Taylor, Professor of Human Retrovirology, Faculty of Medicine, Department of Infectious Disease [Profile] [Researchgate]
- Dr Manon Ragonnet-Cronin, Faculty of Medicine, School of Public Health [GoogleScholar] [ORCID] [Profile] [Researchgate]
- Dr Fabricia F. Nascimento, Research Associate, Faculty of Medicine, School of Public Health [GoogleScholar] [LinkedIN] [ORCID] [Profile] [Researchgate]
- David Jorgensen, Research Postgraduate, Faculty of Medicine, School of Public Health [ORCID] [Profile] [Researchgate]
- Dr Igor Siveroni, Scientific Java Software Developer, Faculty of Medicine, School of Public Health [GoogleScholar] [LinkedIN] [Profile] [Researchgate]
- Dr Rob Johnson, Postdoctoral Research Associate
- Olivia Boyd, Research Postgraduate, Faculty of Medicine, Department of Metabolism, Digestion and Reproduction [ORCID] [Profile] [Researchgate]
- Lily Geidelberg, Research Postgraduate, Department of Infectious Disease Epidemiology [LinkedIN] [Researchgate]
